[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100649752":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":23,"responsibleParty":40,"collaborators":42,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":10,"eligibilityCriteria":53,"healthyVolunteers":49,"sex":54,"minAge":55,"maxAge":10,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":70,"overallStatus":78,"whyStopped":10,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Mucosa Innovations, S.L.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients diagnosed with head and neck cancer and treated with Radiotherapy or Chemoradiotherapy",null,"Retrospective cohort of adult patients diagnosed with and treated for head and neck cancer under routine clinical practice at the Radiation Oncology Department-Centro Oncológico Clara Campal between 2019-2023 Data will be retrospectively recovered from registries from patients who had been treated with radiotherapy (with or without concomitant chemotherapy), and topical oral mucosal measures, and for whom oral mucositis assessments are available throughout at least the RT\u002FCRT treatment period.",[13],{"name":14,"affiliation":15,"role":16},"Mariola García-Aranda Pez","Hospital Universitario HM Sanchinarro - Centro Integral Oncológico Clara Campal","PRINCIPAL_INVESTIGATOR",[18],{"name":19,"role":20,"phone":21,"phoneExt":10,"email":22},"Jorge Manuel Rodríguez-Vilaboa","CONTACT","+34 629288597","jorge.vilaboa@mucosainnovations.com",[24],{"facility":15,"status":10,"city":25,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Madrid","28050","Spain","ES",{"type":30,"coordinates":31},"Point",[32,33],-3.70256,40.4165,{"lat":33,"lon":32},[36,39],{"name":37,"role":20,"phone":38,"phoneExt":10,"email":38},"Mariola García-Aranda Pez, MD","mgaranda@hmhospitales.com",{"name":37,"role":16,"phone":10,"phoneExt":10,"email":10},{"type":41,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[43,45],{"name":15,"class":44},"UNKNOWN",{"name":46,"class":44},"Clínica Vilaboa","100649752","retrospective-observational-study-of-oral-complications-and-quality-of-life-in-head-and-neck-cancer-patients-treated-with-radiotherapy-or-chemoradiotherapy-100649752",false,"NCT07739771","Retrospective Observational Study of Oral Complications and Quality of Life in Head and Neck Cancer Patients Treated With Radiotherapy or Chemoradiotherapy.","Retrospective Evaluation of Severe Oral Mucositis Incidence, Time to Onset and Functional Impact in Quality of Life in Head and Neck Cancer Radiated and Chemo-radiated Patients. Part of the Stop Oral Mucositis Project (STOPOMP)","Inclusion Criteria:\n\n* Adults (≥18 years) diagnosed with head and neck cancer\n* Treated with radiotherapy or chemoradiotherapy, with or without surgery and\u002For immunotherapy, according to tumor type and stage, between 2019 and 2023\n* With available medical records documenting clinical assessments of oral mucositis during at least the radiotherapy\u002FCRT treatment period, and that had used the oral mucosa topical measures\n\nExclusion Criteria:\n\n* Patients with missing or insufficient clinical records required for the study\n* Patients with concomitant malignancies undergoing active treatment at the same time.","ALL","18 Years",{"count":57,"type":58},60,"ESTIMATED","OBSERVATIONAL","Head and Neck cancer patients receiving radiation therapy (with or without chemotherapy) suffer several oral complications, such as oral mucositis, which impairs quality of life of patients during radiotherapy and in the post-treatment follow-up period. The use of topical agents to protect oral mucosa against radiation-induced toxicity is part of the routine clinical practice. Among these products, the use of mouthwashes and\u002For gels are extensively used in the Centro Oncológico Clara Campal - Hospital HM Sanchinarro. Once such product is a proprietary formulation based on natural ingredients such as olive oil, betaine, and xylitol (Mucosa Innovations S.L.).",[62,63,64,65,66,67,68,69],"Oral Mucositis","Quality of Life","Mucositis","Pain","Speech","Saliva","Radiation Toxicity","Chemotherapeutic Toxicity",[62,71,72,65,73,74,75,76,77],"Cancer Therapy Toxic Effect","Cancer Support","Ulcers","Treatment Interruptions","Oral Mucosa","Radiotherapy","Chemotherapy","NOT_YET_RECRUITING","2026-07-28",{"date":81,"type":82},"2026-07-31","ACTUAL",{"date":84,"type":58},"2026-08",{"date":86,"type":58},"2026-10",{"name":5,"class":6},1]